MedPath

University of Oxford

University of Oxford logo
🇬🇧United Kingdom
Ownership
Private
Established
1096-01-01
Employees
10K
Market Cap
-
Website
http://www.ox.ac.uk

AN2 Therapeutics Completes 200-Patient Study Revealing 40% Mortality Rate in Acute Melioidosis

AN2 Therapeutics completed a 200-patient observational study in acute melioidosis, revealing a striking mortality rate of nearly 40% by Day 90 despite standard of care treatment.

Oxford Scientists Develop Single-Shot Malaria Vaccine Using Programmable Microcapsule Technology

University of Oxford researchers have developed a programmable microcapsule delivery system that enables complete malaria vaccination in a single injection, eliminating the need for booster visits.

Oxford and ReciBioPharm Expand Malaria Vaccine Partnership to Advance Two Blood-Stage Candidates

The University of Oxford and ReciBioPharm have expanded their collaboration to manufacture two blood-stage malaria vaccine candidates, R78C and RH5.1, for Phase 1/2 clinical trials.

Common Cytomegalovirus May Enhance Immunotherapy Outcomes in Melanoma Patients, Oxford Study Finds

A groundbreaking University of Oxford study reveals that prior cytomegalovirus (CMV) infection improves melanoma patients' response to single-drug PD-1 immunotherapy while reducing severe side effects.

Circle Pharma to Reveal Dual Mechanism of Novel Cyclin A/B RxL Inhibitors at AACR 2025

Circle Pharma will present late-breaking data at AACR 2025 showing how their novel cyclin A/B RxL inhibitors disrupt DNA repair pathways and affect mitotic progression in E2F-high cancers.

Study Reveals Effective Strategies for Young Adults Quitting Vaping

Nearly half of young adults successfully quit vaping after three months using a combination of phone-based coaching, health apps, and nicotine replacement therapy, according to new research published in the American Journal of Preventive Medicine.

Infinitopes Secures MHRA Approval for Phase I/IIa Trial of Novel Cancer Vaccine Against Oesophageal Adenocarcinoma

Infinitopes has received UK MHRA approval for a first-in-human Phase I/IIa clinical trial of ITOP1, an 'off-the-shelf' precision cancer vaccine designed to prevent recurrence in patients with surgically resectable oesophageal adenocarcinoma.

Epilepsy Drug Ezogabine Shows Promise as Novel Depression Treatment by Targeting Brain Potassium Channels

Two recent studies reveal that ezogabine, an FDA-approved epilepsy medication, may effectively treat depression by normalizing hyperactivity in the brain's reward circuitry through KCNQ potassium channel modulation.

FDA Grants 510(k) Clearance to Dawes-Redman CTG Analysis for Fetal Monitoring in the US

Huntleigh Healthcare's Dawes-Redman CTG Analysis has received FDA 510(k) clearance, bringing the advanced fetal monitoring technology to the US market after 40 years of global use and refinement.

Study Reveals Ozempic's Potential as Depression Treatment in Landmark Analysis

A major study of 30,000 patients demonstrates that GLP-1 receptor agonists like Ozempic and Wegovy may have significant antidepressant effects, opening new therapeutic possibilities.

© Copyright 2025. All Rights Reserved by MedPath